Acute interstitial pneumonitis induced by carbamazepine. 1993

N Takahashi, and H Aizawa, and S Takata, and K Matsumoto, and H Koto, and H Inoue, and N Hara
Research Institute for Diseases of the Chest Faculty of Medicine, Kyushu University, Fukuoka, Japan.

A 62 year old man treated with carbamazepine for 3 months developed eczema and acute interstitial pneumonitis. A lymphocyte-stimulation test was reactive to carbamazepine. Withdrawal of the drug resulted in prompt improvement. Only 10 cases of this type of drug-induced lung disease have previously been reported.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002220 Carbamazepine A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. Amizepine,Carbamazepine Acetate,Carbamazepine Anhydrous,Carbamazepine Dihydrate,Carbamazepine Hydrochloride,Carbamazepine L-Tartrate (4:1),Carbamazepine Phosphate,Carbamazepine Sulfate (2:1),Carbazepin,Epitol,Finlepsin,Neurotol,Tegretol
D003875 Drug Eruptions Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. Dermatitis Medicamentosa,Dermatitis, Adverse Drug Reaction,Maculopapular Drug Eruption,Maculopapular Exanthem,Morbilliform Drug Reaction,Morbilliform Exanthem,Drug Eruption,Drug Eruption, Maculopapular,Drug Eruptions, Maculopapular,Drug Reaction, Morbilliform,Drug Reactions, Morbilliform,Eruption, Drug,Eruption, Maculopapular Drug,Eruptions, Drug,Eruptions, Maculopapular Drug,Exanthem, Maculopapular,Exanthem, Morbilliform,Exanthems, Maculopapular,Exanthems, Morbilliform,Maculopapular Drug Eruptions,Maculopapular Exanthems,Morbilliform Drug Reactions,Morbilliform Exanthems,Reaction, Morbilliform Drug,Reactions, Morbilliform Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D017563 Lung Diseases, Interstitial A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features. Diffuse Parenchymal Lung Disease,Diffuse Parenchymal Lung Diseases,Interstitial Lung Disease,Interstitial Lung Diseases,Pneumonia, Interstitial,Pneumonitis, Interstitial,Interstitial Pneumonia,Interstitial Pneumonias,Interstitial Pneumonitides,Interstitial Pneumonitis,Lung Disease, Interstitial,Pneumonias, Interstitial,Pneumonitides, Interstitial

Related Publications

N Takahashi, and H Aizawa, and S Takata, and K Matsumoto, and H Koto, and H Inoue, and N Hara
March 1984, Acta paediatrica Scandinavica,
N Takahashi, and H Aizawa, and S Takata, and K Matsumoto, and H Koto, and H Inoue, and N Hara
January 2009, Current drug safety,
N Takahashi, and H Aizawa, and S Takata, and K Matsumoto, and H Koto, and H Inoue, and N Hara
January 2012, Respiratory medicine case reports,
N Takahashi, and H Aizawa, and S Takata, and K Matsumoto, and H Koto, and H Inoue, and N Hara
July 1991, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
N Takahashi, and H Aizawa, and S Takata, and K Matsumoto, and H Koto, and H Inoue, and N Hara
September 2006, Respiratory medicine,
N Takahashi, and H Aizawa, and S Takata, and K Matsumoto, and H Koto, and H Inoue, and N Hara
January 2014, Case reports in hematology,
N Takahashi, and H Aizawa, and S Takata, and K Matsumoto, and H Koto, and H Inoue, and N Hara
January 2004, The European respiratory journal,
N Takahashi, and H Aizawa, and S Takata, and K Matsumoto, and H Koto, and H Inoue, and N Hara
January 2009, BMJ case reports,
N Takahashi, and H Aizawa, and S Takata, and K Matsumoto, and H Koto, and H Inoue, and N Hara
May 1995, Revue du rhumatisme (English ed.),
N Takahashi, and H Aizawa, and S Takata, and K Matsumoto, and H Koto, and H Inoue, and N Hara
February 1994, The Medical journal of Australia,
Copied contents to your clipboard!